Investor Relations

Regulation

SEC Proposal Protects Executives, Hamstrings Investors

Proposed rule changes would pressure proxy advisory firms to take a more management-friendly stance in their reports and vote recommendations.

David McCann
November 6, 2019
Investor Relations

Why an Investor Soured on Softbank

Vitaliy Katsenelson revered Softbank's founder and thought he'd own the company's stock for decades. Why he changed his mind is instructive for CFOs.
Regulation

Investors Want a Clear Story on CECL. Are CFOs Ready to Tell It?

Communicating credit risk model changes to investors may be the most challenging aspect of the new Current Expected Credit Loss accounting standard.
Credit

The Link Between Capital Structure and Financial Flexibility

New research shows that companies decrease leverage in anticipation of future investment shocks — good ones and bad ones alike.
Investor Relations

After 21 Years and a Spinoff, Profitability Finally Arrives

Ironwood Pharmaceuticals is in the black for the first time thanks to its complex spinoff of pre-commercial drug development programs.
Auditing

Audit Committees Boost Disclosure to Shareholders

Investors get more information about the selection and evaluation of large companies' independent auditors.
M&A

Pernod Ricard to Buy Bourbon Whiskey Maker Castle Brands For $223M

The per-share offer price represented a 92% premium to the 67 cents at which Castle Brands shares closed Wednesday.
M&A

Deals Made During Downturns Create More Value

While companies are naturally conservative with cash when the economy goes bad, it may be a good time to consider making acquisitions, research suggests.
Regulation

SEC Charges Drug Firm with Reg FD Violations

In calls and emails, TherapeuticsMD shared material, nonpublic information about a new drug's likelihood of FDA approval with sell-side analysts.
The Economy

Will Inverted Yield Curve Invite Economic Chaos?

Some experts say markets are in for a nightmarish ride; others believe the yield-curve inversion won't trigger an economic crisis, as past inversions have.
Credit

Consumers Boost Citigroup’s Second-Quarter Performance

The first major bank earnings report demonstrates consumers may be key to the second-quarter profits of the largest financial institutions.
Credit & Capital

Big Health Care Companies Are Undervalued

McKesson and Walgreens are strong, healthy companies, despite recent downturns in their stock prices, a CEO in the investment field says.
1 2 3 … 25

Latest Articles

The Economy

U.S. Job Growth Slows Unexpectedly to 145,000

January 10, 2020
General Electric
People

Was GE's New CFO a Risky Choice?

January 10, 2020
Risk Management

U.S. Billion Dollar Weather Disasters Doubled in Last Decade

January 10, 2020
People

CFOs On the Move: Week Ending January 10

January 10, 2020
Financial Performance

WD-40 Shares Dive 4% as Sales Slump in China

January 10, 2020